Author:
Bombardieri Emilio,Alessi Alessandra,Pallotti Federica,Serafini Gianluca,Mazzuca Nicola,Seregni Ettore,Crippa Flavio
Publisher
Springer Berlin Heidelberg
Reference70 articles.
1. Adler LP, Bakale G (2001) Positron emission tomography imaging. In: Khalkali I, Maublant JC, Goldsmith SJ (eds) Nuclear oncology. Diagnosis and therapy. Lippincott Williams & Wilkins, Philadelphia 289–295
2. Agresti R, Crippa F, Gerali A et al (2004) Lymph node metastases detection by FDG-PET and sentinel node biopsy in breast cancer patients: comparison of these different approaches. ESSOI Congress
3. Aide N, Huchet V, Switsers O et al (2007) Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence. Nucl Med Commun 28:267–272
4. Avril N, Dose J, Janicke F et al (1996) Metabolic characterization of breast tumours with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol 14:1848–1857
5. Avril N, Scheidhauer K, Kuhun W (2000) Breast cancer. In: Helmut J, Wieler R, Coleman E (eds) PET in clinical oncology. Springer, New York, 355–372